Effects of NIDDM on Very-Low-Density Lipoprotein Triglyceride and Apolipoprotein B Metabolism: Studies Before and After Sulfonylurea Therapy

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Diabetes

• Publication date

  1986-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2337/diab.35.11.1268PMID 3530855
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lipoprotein lipase activity and serum lipoproteins in untreated Type 2 (insulin-independent) diabetes associated with obesity

  2004cited by this paper
• Multiple disturbances of free fatty acid metabolism in noninsulin-dependent diabetes. Effect of oral hypoglycemic therapy.

  1985cited by this paper
• Development of an integrated model for analysis of the kinetics of apolipoprotein B in plasma very low density lipoproteins, intermediate density lipoproteins, and low density lipoproteins.

  1985cited by this paper
• Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease.

  1985cited by this paper
• Influence of obesity on the metabolism of apolipoprotein B in humans.

  1985cited by this paper
• The effect of diabetic control on very low-density lipoprotein--triglyceride metabolism in patients with type II diabetes mellitus and marked hypertriglyceridemia.

  1984cited by this paper
• The impact of sulfonylurea treatment upon the mechanisms responsible for the insulin resistance in type II diabetes.

  1984cited by this paper
• Plasma and Lipoprotein Cholesterol and Triglyceride in the Pima Indian Population: Comparison of Diabetics and Nondiabetics

  1984cited by this paper
• Prolonged sulfonylurea administration decreases insulin resistance and increases insulin secretion in non-insulin-dependent diabetes mellitus: evidence for improved insulin action at a postreceptor site in hepatic as well as extrahepatic tissues.

  1984cited by this paper
• Mechanism of Improvement in Glucose Metabolism After Chronic Glyburide Therapy

  1984cited by this paper
• The Response of Plasma Triglyceride, Cholesterol, and Lipoprotein Lipase to Treatment in Non-insulin-dependent Diabetic Subjects Without Familial Hypertriglyceridemia

  1983cited by this paper
• Improvement in in vitro insulin action after one month of insulin therapy in obese noninsulin-dependent diabetics. Measurements of glucose transport and metabolism, insulin binding, and lipolysis in isolated adipocytes.

  1983cited by this paper
• Serum lipids and Lipoproteins in type 2 diabetes

  1983cited by this paper
• Isopropanol precipitation method for the determination of apolipoprotein B specific activity and plasma concentrations during metabolic studies of very low density lipoprotein and low density lipoprotein apolipoprotein B.

  1983cited by this paper
• Very-Low-Density Lipoprotein Triglyceride Metabolism in Non-insulin-dependent Diabetes Mellitus: Relationship to Plasma Insulin and Free Fatty Acids

  1983cited by this paper
• Plasma and lipoprotein cholesterol and triglyceride concentrations in the Pima Indians: distributions differing from those of Caucasians.

  1983cited by this paper
• A microfluorometric method for the determination of free fatty acids in plasma.

  1983cited by this paper
• Overproduction of a kinetic subclass of VLDL-apoB, and direct catabolism of VLDL-apoB in human endogenous hypertriglyceridemia: an analytical model solution of tracer data.

  1983cited by this paper
• Dietary effects on very low-density lipoproteins in type 2 (non-insulin-dependent) diabetes mellitus

  1982cited by this paper
• The effect of intensive dietary therapy on serum high density lipoprotein cholesterol in patients with type 2 (non-insulin-dependent) diabetes mellitus: A prospective study

  1982cited by this paper
• Effect of treatment on the concentration of lipoproteins and the postheparin-lipolytic activity in the plasma of noninsulin-dependent diabetics

  1982cited by this paper
• Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes.

  1982cited by this paper
• Integrated Regulation of Very Low Density Lipoprotein Triglyceride and Apolipoprotein-B Kinetics in Non-insulin-dependent Diabetes Mellitus

  1982cited by this paper
• Effect of Sulfonylurea Treatment on In Vivo Insulin Secretion and Action in Patients With Non-insulin-dependent Diabetes Mellitus

  1982cited by this paper
• Very low density lipoprotein metabolism in non-ketotic diabetes mellitus: Effect of dietary restriction

  1982cited by this paper
• Metabolism of Cholesterol and Plasma Triglycerides in Nonketotic Diabetes Mellitus

  1982cited by this paper
• Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia.

  1981cited by this paper
• An Improved Method for the Determination of the Plasma Volume with Evans Blue

  1981cited by this paper
• Diabetic Hypertriglyceridemia: Evidence for Three Clinical Syndromes

  1981cited by this paper
• Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics, and plasma triglyceride levels in normotriglyceridemic man.

  1981cited by this paper
• Dissociation of apoprotein B and triglyceride production in very-low-density lipoproteins.

  1980cited by this paper
• Mechanism of hypertriglyceridaemia in diabetic patients with fasting hyperglycaemia

  1980cited by this paper
• Studied of very low density lipoprotein triglyceride metabolism in an obese population with low plasma lipids: lack of influence of body weight or plasma insulin.

  1980cited by this paper
• A micromethod for assay of lipoprotein lipase activity in needle biopsy samples of human adipose tissue and skeletal muscle.

  1980cited by this paper
• Effects of diet on apoprotein E levels and on the apoprotein E subspecies in human plasma lipoproteins.

  1980cited by this paper
• Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia

  1980cited by this paper
• Apolipoprotein B metabolism in normal, type IV and type V hyperlipoproteinemic subjects.

  1980cited by this paper
• Kinetic bases of the primary hyperlipidaemias: studies of apolipoprotein B turnover in genetically defined subjects.

  1980cited by this paper
• Atherogenesis: a postprandial phenomenon.

  1979cited by this paper
• Transport of very low density lipoprotein triglycerides in varying degrees of obesity and hypertriglyceridemia.

  1979cited by this paper
• Insulin-independent diabetes: A defect in the activity of lipoprotein lipase in adipose tissue

  1979cited by this paper
• Changes in plasma lipoproteins accompanying diet therapy in obese diabetics.

  1979cited by this paper
• Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance

  1979cited by this paper
• The effects of chlorpropamide and insulin on serum lipids, lipoproteins and fractional triglyceride removal

  1978cited by this paper
• A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

  1978cited by this paper
• The effects of prolonged fasting on plasma triglyceride kinetics in man.

  1977cited by this paper
• Postheparin Plasma Lipoprotein Lipase and Hepatic Lipase in Diabetes Mellitus: Relationship to Plasma Triglyceride Metabolism

  1977cited by this paper
• Metabolism of Very Low Density Lipoproteins in Hyperlipidaemia: Studies of Apolipoprotein B Kinetics in Man

  1976cited by this paper
• An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma.

  1975cited by this paper
• Radioimmunological determination of human C-peptide in serum

  1975cited by this paper
• Effect of Fat Cell Size, Restrictive Diet and Diabetes on Lipoprotein Lipase Release by Human Adipose Tissue*

  1975cited by this paper
• Determinants of human adipose tissue lipoprotein lipase. Effect of diabetes and obesity on basal- and diet-induced activity.

  1975cited by this paper
• [Plasma triglyceride metabolism].

  1975cited by this paper
• Inter-relationship between insulin secretion and plasma free fatty acid and triglyceride transport kinetics in maturity onset diabetes and the effect of phenethylbiguanide (Phenformin)

  1974cited by this paper
• Plasma triglyceride transport kinetics in diabetes mellitus.

  1973cited by this paper
• Quantitative determination of serum triglycerides by the use of enzymes.

  1973cited by this paper
• Coated charcoal immunoassay of insulin.

  1965cited by this paper

• In-vivo Anti-Diabetic Efficacy of Silver Nanoparticles from Marine Brown Seaweed Colpomenia sinuosa on Alloxan Stimulated Hyperglycemic Activity in Wistar Albino Rats

  2022cites this paper
• ANTI-HYPERGLYCEMIC EFFECTS OF ETHANOLIC EXTRACT OF SYZYGIUM ALTERNIFOLIUM (WIGHT) WALP. IN ALLOXAN INDUCED DIABETES RAT MODELS

  2020cites this paper
• Single and combinatorial herbal formulations reversed hyperglycemia and dyslipidemia in diabetic rats

  2019cites this paper
• Action of corilagin on hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats.

  2019cites this paper
• Antidiabetic and antihyperlipidemic effects of ethanolic Ferula assa-foetida oleo-gum-resin extract in streptozotocin-induced diabetic wistar rats.

  2019cites this paper
• Moringa concanensis Nimmo ameliorates hyperglycemia in 3T3-L1 adipocytes by upregulating PPAR-γ, C/EBP-α via Akt signaling pathway and STZ-induced diabetic rats.

  2018cites this paper
• Trigonelline attenuates hepatic complications and molecular alterations in high-fat high-fructose diet-induced insulin resistance in rats.

  2017cites this paper
• PREVALENCE OF DYSLIPIDEMIA IN NEWLY DIAGNOSED TYPE 2 DIABETES PATIENTS AT DIAGNOSED AT KGNTH BANNU

  2017cites this paper
• Common dyslipidemias, high lipoprotein(a) concentrations and endothelial function in the children of the STRIP study families

  2016cites this paper
• The role of lipids in the pathogenesis and treatment of type 2 diabetes and associated co-morbidities

  2016cites this paper
• HDL & LDL Status in Untreated Newly Detected Type 2 Diabetic Patients

  2015cites this paper
• Evaluation of Anti-Hyperglycemic Activity of Kariveppilai Churnam in Alloxan Induced Diabetic Rats

  2015cites this paper
• Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone*

  2015cites this paper
• Gliquidone versus metformin: differential effects on aorta in streptozotocin induced diabetic rats

  2014cites this paper
• Novel CoQ10 Antidiabetic Mechanisms Underlie Its Positive Effect: Modulation of Insulin and Adiponectine Receptors, Tyrosine Kinase, PI3K, Glucose Transporters, sRAGE and Visfatin in Insulin Resistant/Diabetic Rats

  2014cites this paper
• Etude de la capacité d'inhibition de l'apolipoprotéine C1 sur l'activité de la protéine de transfert des esters de cholestérol chez des patients coronariens normolipidémiques et hyperlipidémiques et chez des patients diabétiques

  2013cites this paper
• Ursolic acid and rosiglitazone combination alleviates metabolic syndrome in high fat diet fed C57BL/6J mice.

  2012cites this paper
• Effect of iridoid glucoside on streptozotocin induced diabetic rats and its role in regulating carbohydrate metabolic enzymes.

  2012cites this paper
• Retinol-Binding Protein 4 Is an Independent Factor Associated With Triglycerides and a Determinant of Very Low-Density Lipoprotein–Apolipoprotein B100 Catabolism in Type 2 Diabetes Mellitus

  2012cites this paper
• Diabetes Mellitus and Cardiovascular Disease

  2011cites this paper
• Lipid Droplets and Very Low Density Lipoproteins; Their Relation to Insulin Resistance

  2011cites this paper
• A study on the protective effect of Cynodon dactylon leaves extract in diabetic rats.

  2011cites this paper
• Antidiabetogenic action of Morus rubra L. leaf extract in streptozotocin‐induced diabetic rats

  2010cites this paper
• DIABETES, DYSLIPIDEMIA, ANTIOXIDANT AND STATUS OF OXIDATIVE STRESS

  2010cites this paper
• Protective effect of Morus rubra L. leaf extract on diet-induced atherosclerosis in diabetic rats.

  2010cites this paper
• Pharmacology and chemistry of diabetes mellitus and antidiabetic drugs: a critical review.

  2010cites this paper
• Abnormalities in Plasma Concentration of Lipids and Fibrinogen of Egyptian Microalbuminuric NIDDM Type 2 Diabetic Patients

  2010cites this paper
• Lipid abnormalities in streptozotocin-diabetes: Amelioration by Morus indica L. cv Suguna leaves

  2009cites this paper
• Hydrangea dulcis folium preserves beta-cell mass in diabetic db/db mice.

  2009cites this paper
• Westernized-like-diet-fed rats: effect on glucose homeostasis, lipid profile, and adipocyte hormones and their modulation by rosiglitazone and glimepiride.

  2009cites this paper
• Improvement of diabetic complication by hydrangea dulcis folium in streptozotocin-induced diabetic rats.

  2009cites this paper
• Metabolic disorders of acute exposure to malathion in adult Wistar rats.

  2009cites this paper
• Effects of 20 mg rosuvastatin on VLDL1-, VLDL2-, IDL- and LDL-ApoB kinetics in type 2 diabetes

  2008cites this paper
• The effects of medications used for the management of diabetes and obesity on postprandial lipid metabolism.

  2008cites this paper
• Hypoglycemic effects of Ganoderma applanatum and Collybia confluens exo‐polymers in streptozotocin‐induced diabetic rats

  2007cites this paper
• Physiopathologie de la dyslipidémie du syndrome métabolique et du diabète de type 2

  2007cites this paper
• Interrelationship of antioxidative status, lipid peroxidation, and lipid profile in insulin-dependent and non-insulin-dependent diabetic patients.

  2007cites this paper
• Studies on the glycemic and lipidemic effect of Murraya koenigii in experimental animals.

  2007cites this paper
• Improvement of Lipid Profile by Amaranth (Amaranthus esculantus) Supplementation in Streptozotocin-Induced Diabetic Rats

  2006cites this paper
• Thematic review series: Patient-Oriented Research. Recent advances in liver triacylglycerol and fatty acid metabolism using stable isotope labeling techniques Published, JLR Papers in Press, June 1, 2006.

  2006cites this paper
• Lipid and lipoprotein profiles in Ethiopian patients with diabetes mellitus.

  2006cites this paper
• BENEFICIAL EFFECTS OF ALOE VERA LEAF GEL EXTRACT ON LIPID PROFILE STATUS IN RATS WITH STREPTOZOTOCIN DIABETES

  2006cites this paper
• Mechanisms, Significance and Treatment of Vascular Dysfunction in Type 2 Diabetes Mellitus

  2005cites this paper
• Overproduction of VLDL1 Driven by Hyperglycemia Is a Dominant Feature of Diabetic Dyslipidemia

  2005cites this paper
• New insight into the pathophysiology of lipid abnormalities in type 2 diabetes.

  2005cites this paper
• Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes

  2005cites this paper
• Lipoprotein-matrix interactions in macrovascular disease in diabetes.

  2004cites this paper
• Narrative Review: Hepatobiliary Disease in Type 2 Diabetes Mellitus

  2004cites this paper
• Protective Role of Phaseolus vulgaris on Changes in the Fatty Acid Composition in Experimental Diabetes

  2004cites this paper
• Vascular and Platelet Function in Insulin Resistance

  2004cites this paper
• Hyperlipidémie des diabétiques

  2004cites this paper
• The effect of high‐fat and high‐fructose diets on glucose tolerance and plasma lipid and leptin levels in rats

  2004cites this paper
• Dyslipidemia in type 2 diabetes.

  2004cites this paper
• Lack of effect of acute repaglinide administration on postprandial lipaemia in patients with type 2 diabetes mellitus.

  2003cites this paper
• Effect of Cogent db, a herbal drug, on serum and tissue lipid metabolism in experimental hyperglycaemic rats

  2003cites this paper
• Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease.

  2003cites this paper
• Diabetic dyslipidaemia: from basic research to clinical practice*

  2003cites this paper
• Protective effect of Coccinia indica on changes in the fatty acid composition in streptozotocin induced diabetic rats.

  2003cites this paper
• Protective effects of ferulic acid on hyperlipidemic diabetic rats

  2003cites this paper
• Effect of pinealectomy on plasma levels of insulin and leptin and on hepatic lipids in type 2 diabetic rats

  2003cites this paper
• Apolipoprotein E kinetics: influence of insulin resistance and type 2 diabetes

  2002cites this paper
• Antidiabetic effect of Cogent db, a herbal drug in alloxan-induced diabetes mellitus.

  2002cites this paper
• Type 2 diabetes outcomes.

  2002cites this paper
• Lipids in Type 2 Diabetes

  2002cites this paper
• Long‐term melatonin administration reduces hyperinsulinemia and improves the altered fatty‐acid compositions in type 2 diabetic rats via the restoration of Δ‐5 desaturase activity

  2002cites this paper
• Triglyceride-rich lipoproteins from subjects with type 2 diabetes do not demonstrate increased binding to biglycan, a vascular proteoglycan.

  2002cites this paper
• Controversies in Management of Diabetes in Patients with Coronary Heart Disease

  2002cites this paper
• Subgrupos especiales en cardiopatía isquémica. el paciente diabético. el paciente anciano. cardiopatía isquémica en la mujer. el paciente no revascularizable de forma convencional

  2001cites this paper
• Insulin Treatment in Type 2 Diabetes

  2001cites this paper
• Nutritional management for type 2 diabetes

  2001cites this paper
• HDL kinetics, fish oils and diabetes.

  2001cites this paper
• The Pancreas and Lipoprotein Metabolism

  2001cites this paper
• Glibenclamide improves postprandial hypertriglyceridaemia in Type 2 diabetic patients by reducing chylomicrons but not the very low‐density lipoprotein subfraction levels

  2001cites this paper
• Impact of sulfonylurea receptor 1 genetic variability on non-insulin-dependent diabetes mellitus prevalence and treatment: a population study.

  2001cites this paper
• Hepatic apolipoprotein E expression promotes very low density lipoprotein-apolipoprotein B production in vivo in mice.

  2000cites this paper
• Effects of three months' diet after diagnosis of Type 2 diabetes on plasma lipids and lipoproteins (UKPDS 45)

  2000cites this paper
• The Insulin Resistance Syndrome: Impact on Lipoprotein Metabolism and Atherothrombosis

  2000cites this paper
• Very low density lipoprotein subfractions in Type II diabetes mellitus: alterations in composition and susceptibility to oxidation

  2000cites this paper
• Diabetes Mellitus and Vascular Disease Risk

  2000cites this paper
• Significant improvement of apolipoprotein B-containing lipoprotein metabolism by insulin treatment in patients with non-insulin-dependent diabetes mellitus

  2000cites this paper
• Interaction between the Asn291Ser variant of the LPL gene and insulin resistance on dyslipidaemia in high risk individuals for Type 2 diabetes mellitus

  2000cites this paper
• Metabolic syndrome X: a review.

  2000cites this paper
• Metabolic abnormalities of apolipoprotein B‐containing lipoproteins in non‐insulin‐dependent diabetes: a stable isotope kinetic study

  2000cites this paper
• The effects of tolbutamide on lipoproteins, lipoprotein lipase and hormone-sensitive lipase.

  1999cites this paper
• Antidiabetic and hypolipidemic effects of Momordica cymbalaria Hook. fruit powder in alloxan-diabetic rats.

  1999cites this paper
• Co-ordination of hepatic and adipose tissue lipid metabolism after oral glucose.

  1999influential citation
• Dyslipidaemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis.

  1999cites this paper
• Effects of insulin therapy and glycemic control on distribution of HDL alpha and pre-beta subfractions in non insulin-dependent diabetic subjects.

  1999cites this paper
• A stable isotope method using a [(2)H(5)]glycerol bolus to measure very low density lipoprotein triglyceride kinetics in humans.

  1999cites this paper
• Role of human liver lipogenesis and reesterification in triglycerides secretion and in FFA reesterification.

  1998cites this paper
• Lipid and Lipoprotein Responses to Oral Combined Hormone Replacement Therapy in Normolipemic Obese Women with Controlled Type 2 Diabetes Mellitus

  1998cites this paper
• Role of human liver lipogenesis and reesterification in triglycerides secretion and in FFA reesterification.

  1998cites this paper
• Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: an hypothesis.

  1998cites this paper
• The Effect of Treatment Types on Plasma Levels of Lipoproteins, Apolipoproteins and LCAT in Type II Diabetes Mellitus

  1998cites this paper
• Management of Dyslipidemia in Adults With Diabetes

  1998cites this paper
• Management of Dyslipidemia in Adults With Diabetes

  1998cites this paper
• Measuring lipogenesis and cholesterol synthesis in humans with deuterated water: use of simple gas chromatographic/mass spectrometric techniques.

  1997cites this paper
• Insulin and Sulfonylurea Therapy in NIDDM Patients: Are the Effects on Lipoprotein Metabolism Different Even With Similar Blood Glucose Control?

  1997cites this paper
• Insulin resistance implications for type II diabetes mellitus and coronary heart disease.

  1997cites this paper
• Effect of Oral Antidiabetics and Insulin on Lipids and Coronary Heart Disease in Non‐Insulin‐dependent Diabetes Mellitus

  1997cites this paper